Only 4% of patients experienced SCD for neither sST2 nor NT-proBNP above the ROC-derived cut-off points; 34% for either of the biomarkers above; and 71% for both biomarkers above. The gene discussed is NPPB; the disease is Schnyder corneal dystrophy.